Prot-Bertoye Caroline, Lebbah Saïd, Daudon Michel, Tostivint Isabelle, Bataille Pierre, Bridoux Franck, Brignon Pierre, Choquenet Christian, Cochat Pierre, Combe Christian, Conort Pierre, Decramer Stéphane, Doré Bertrand, Dussol Bertrand, Essig Marie, Gaunez Nicolas, Joly Dominique, Le Toquin-Bernard Sophie, Méjean Arnaud, Meria Paul, Morin Denis, N'Guyen Hung Viet, Noël Christian, Normand Michel, Pietak Michel, Ronco Pierre, Saussine Christian, Tsimaratos Michel, Friedlander Gérard, Traxer Olivier, Knebelmann Bertrand, Courbebaisse Marie
Due to the number of contributing authors,the affiliations are provided in the Supplemental Material.
Clin J Am Soc Nephrol. 2015 May 7;10(5):842-51. doi: 10.2215/CJN.06680714. Epub 2015 Feb 25.
Cystinuria is an autosomal recessive disorder affecting renal cystine reabsorption; it causes 1% and 8% of stones in adults and children, respectively. This study aimed to determine epidemiologic and clinical characteristics as well as comorbidities among cystinuric patients, focusing on CKD and high BP.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective study was conducted in France, and involved 47 adult and pediatric nephrology and urology centers from April 2010 to January 2012. Data were collected from 442 cystinuric patients.
Median age at onset of symptoms was 16.7 (minimum to maximum, 0.3-72.1) years and median diagnosis delay was 1.3 (0-45.7) years. Urinary alkalinization and cystine-binding thiol were prescribed for 88.8% and 52.2% of patients, respectively, and 81.8% had at least one urological procedure. Five patients (1.1%, n=4 men) had to be treated by dialysis at a median age of 35.0 years (11.8-70.7). Among the 314 patients aged ≥16 years, using the last available plasma creatinine, 22.5% had an eGFR≥90 ml/min per 1.73 m(2) (calculated by the Modification of Diet in Renal Disease equation), whereas 50.6%, 15.6%, 7.6%, 2.9%, and 0.6% had an eGFR of 60-89, 45-59, 30-44, 15-29, and <15, respectively. Among these 314 patients, 28.6% had high BP. In multivariate analysis, CKD was associated with age (odds ratio, 1.05 [95% confidence interval, 1.03 to 1.07]; P<0.001), hypertension (3.30 [1.54 to 7.10]; P=0.002), and severe damage of renal parenchyma defined as a past history of partial or total nephrectomy, a solitary congenital kidney, or at least one kidney with a size <10 cm in patients aged ≥16 years (4.39 [2.00 to 9.62]; P<0.001), whereas hypertension was associated with age (1.06 [1.04 to 1.08]; P<0.001), male sex (2.3 [1.3 to 4.1]; P=0.003), and an eGFR<60 ml/min per 1.73 m(2) (2.7 [1.5 to 5.1]; P=0.001).
CKD and high BP occur frequently in patients with cystinuria and should be routinely screened.
胱氨酸尿症是一种常染色体隐性疾病,影响肾脏对胱氨酸的重吸收;分别导致成人和儿童1%和8%的结石形成。本研究旨在确定胱氨酸尿症患者的流行病学和临床特征以及合并症,重点关注慢性肾脏病(CKD)和高血压(BP)。
设计、地点、参与者及测量方法:这项回顾性研究在法国开展,于2010年4月至2012年1月纳入了47个成人及儿童肾脏病和泌尿外科中心。收集了442例胱氨酸尿症患者的数据。
症状出现的中位年龄为16.7岁(最小至最大,0.3 - 72.1岁),中位诊断延迟为1.3年(0 - 45.7年)。分别有88.8%和52.2%的患者接受了尿碱化和胱氨酸结合硫醇治疗,81.8%的患者至少接受了一次泌尿外科手术。5例患者(1.1%,n = 4名男性)在35.0岁(11.8 - 70.7岁)的中位年龄时需要接受透析治疗。在314例年龄≥16岁的患者中,根据最后一次可用的血肌酐水平,22.5%的患者估算肾小球滤过率(eGFR)≥90 ml/(min·1.73 m²)(根据肾脏病饮食改良公式计算),而eGFR为60 - 89、45 - 59、30 - 44、15 - 29和<15的患者分别占50.6%、15.6%、7.6%、2.9%和0.6%。在这314例患者中,28.6%患有高血压。多因素分析显示,慢性肾脏病与年龄相关(比值比,1.05 [95%置信区间,1.03至1.07];P<0.001)、高血压(3.30 [1.54至7.10];P = 0.002)以及肾实质严重损害相关,肾实质严重损害定义为有部分或全肾切除病史、先天性单肾或年龄≥16岁患者中至少一个肾脏大小<10 cm(4.39 [2.00至9.62];P<0.001),而高血压与年龄相关(1.06 [1.04至1.08];P<0.001)、男性(2.3 [1.3至4.1];P = 0.003)以及eGFR<60 ml/(min·1.73 m²)相关(2.7 [1.5至5.1];P = 0.001)。
胱氨酸尿症患者中慢性肾脏病和高血压很常见,应常规进行筛查。